DUBLIN–(BUSINESS WIRE)–The “Diabetic Retinopathy Ongoing Global Clinical Trials Analysis and Outlook” report has been added to ResearchAndMarkets.com’s offering. Diabetic Retinopathy ongoing clinical trials report provides comprehensive analysis and …
Author: Business Wire
Alzheimer’s Therapeutics Research Leader Dr. Roy Twyman Joins NeuroVision Imaging Board
SACRAMENTO, Calif.–(BUSINESS WIRE)–#Alzheimers–Roy Ervin Twyman, MD, PhD, will join the NeuroVision Imaging Inc. Board of Directors on July 20.
首尔半导体的LED “SunLike”产品临床试验结果显示：对眼部健康和睡眠质量具有改善效果
韩国 安山–(BUSINESS WIRE)–全球领先的LED企业首尔半导体(KOSDAQ 046890)宣布：临床试验证明，以人为本的照明产品“SunLike“对眼部健康的睡眠质量具有改善效果。
ソウル半導体の自然光LED、臨床試験で、目の疲労や睡眠の質に効果
韓国安山市–(BUSINESS WIRE)–世界的なLED (発光ダイオード)専業メーカーのSeoul Semiconductor Co., Ltd. (本社：韓国安山市、代表理事：李貞勲、以下「ソウル半導体」)は、自社の先端技術で開発した自然光LEDの”SunLike”が睡眠の質の向上と目の健康に有益な、ヒューマンセントリック照明に最適化されたLED製品であるという研究結果が出たと発表した。
Global Glaucoma Market – Clinical Trials Analysis & Outlook to 2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Glaucoma Ongoing Global Clinical Trials Analysis and Outlook” report has been added to ResearchAndMarkets.com’s offering. Glaucoma ongoing clinical trials report provides comprehensive analysis and trends in global Glaucom…
Aerie Pharmaceuticals Announces Appointment of Randall Brown as Director, Payer Marketing
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of Randall Brown as Director, Payer Marketing, reporting to Deanne Melloy, Aerie’s Vice President of Marketing. Mr. Brown will support the ongoing development and execution of strate
Global Dry Eye Syndrome Analysis, Trends, Market Size & Forecasts up to 2024, With an Expected CAGR of 4.8% – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Syndrome: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global dry eye syndrome to grow with a CAGR of 4…
Vivior a clôturé un tour de financement avec des investisseurs privés originaires d’Europe et des États-Unis
ZURICH–(BUSINESS WIRE)–La cataracte, ou opacification du cristallin, affecte plus de 50 millions de personnes chaque année à travers le monde. Le traitement standard consiste à implanter une lentille intraoculaire (LIO) artificielle. Les chirurgiens ophtalmologistes s’appuient actuellement sur des entretiens subjectifs avec les patients pour choisir la puissance et le type de lentille intraoculaire artificielle, ce qui peut conduire à des résultats décevants pour les patients si ce choix n’es
Vivior hat Finanzierungsrunde mit privaten Investoren aus Europa und den USA abgeschlossen
ZÜRICH–(BUSINESS WIRE)–Weltweit sind mehr als 50 Millionen Menschen pro Jahr vom grauen Star, der Trübung der Linse des Auges, betroffen. Die Implantation einer künstlichen Intraokularlinse (IOL) ist dabei die übliche Behandlungsmethode. Augenchirurgen wählen die Brechkraft und den Typ der IOL aufgrund von Gesprächen mit den Patienten, was infolge der subjektiven Informationen zu unbefriedigenden Ergebnissen führen kann, wenn die Wahl der Linse nicht korrekt oder passend ist. Ein neuartiges t
Resumen: Vivior cierra ronda de financiación con inversores privados de Europa y EE. UU.
ZURICH–(BUSINESS WIRE)–Las cataratas, la opacidad de la lente del ojo, afectan a más de 50 millones personas cada año en todo el mundo. El tratamiento habitual consiste en implantar una lente intraocular artificial (IOL en sus siglas en inglés). En la actualidad, los cirujanos oftálmicos confían en entrevistas subjetivas a los pacientes al seleccionar la potencia y el tipo de IOL, lo que puede derivar en resultados insatisfactorios para los pacientes si esta opción no es exacta o adecuada. Un
Samenvatting: Vivior heeft financieringsronde met particuliere investeerders uit Europa en de VS gesloten
ZURICH–(BUSINESS WIRE)–Vivior closed financing round with private investors from Europe and the US
Riassunto: Vivior conclude un round di finanziamento con investitori privati di Europa e Stati Uniti
ZURIGO–(BUSINESS WIRE)–La cataratta, l’annebbiamento del cristallino, è una patologia oculare che colpisce ogni anno oltre 50 milioni di persone nel mondo. Il trattamento standard prevede l’impianto di una lente intraoculare artificiale (IOL). Attualmente i chirurghi oftalmici selezionano il tipo e la gradazione della lente IOL in base a interviste soggettive dei pazienti ma, se la scelta non è precisa o adatta, i risultati per i pazienti possono essere insoddisfacenti. Un nuovo sistema indos
Seoul Semiconductor’s LED SunLike Improves Eye Health and Sleep Quality, According to Clinical Study
ANSAN, South Korea–(BUSINESS WIRE)–#HomeLightings–Seoul Semiconductor LED SunLike is a human centric lighting that improves eye health and sleep quality.
Oyster Point Pharma Announces Positive Results from Phase 2 Clinical Trial of the Company’s Investigational Treatment for Dry Eye Disease
PRINCETON, N.J.–(BUSINESS WIRE)–#AECOS–Oyster Point Pharma, Inc., today announced results from the PEARL study, a Phase 2b clinical trial evaluating the company’s novel therapy for the treatment of Dry Eye Disease (DED). The study met both sign and symptom primary endpoints by showing a statistically significant improvement in each compared to a vehicle control. Topline data from the study will be presented at the American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium in Deer Vall
Vivior Closed Financing Round with Private Investors from Europe and The US
ZURICH–(BUSINESS WIRE)–Vivior closed financing round with private investors from Europe and the US
Global Fundus Cameras Market 2018-2022 | Growing Demand for Hybrid Cameras to Drive Growth | Technavio
LONDON–(BUSINESS WIRE)–#Cameras–The global fundus cameras market is expected to register a CAGR of over 5% during the period 2018-2022, according to Technavio.
Fiber Optic Sensors Markets 2016-2024 – Global Strategic Business Report 2018 With Annual Estimates & Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Fiber Optic Sensors – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Lati…
Hercules Capital Proudly Announces Eight Portfolio Companies Have Completed or Announced an IPO or M&A Liquidity Event Year-to-Date 2018
PALO ALTO, Calif.–(BUSINESS WIRE)–Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, is pleased to announce the latest liquidity events for eight (8) of its portfolio companies: DocuSign, Inc., Tricida, Inc. and BridgeBio Inc./Eidos Therapeutics, Inc., which recently completed their initial public offerings (“IPO”); and Inotek Pharmaceuticals Corporati
Optical Imaging Market: By Technology Market, Photo-Acoustic Tomography Market, Others By Geography – Forecast 2014-2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Imaging Market: By Technology Market, Photo-Acoustic Tomography Market, Others By Geography – Forecast 2014-2020” report has been added to ResearchAndMarkets.com’s offering. The publisher classifies optical Imaging…
Glaucoma in Europe: Epidemiology & Patient Flow Analysis – 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Glaucoma Epidemiology and Patient Flow Analysis – 2018” report has been added to ResearchAndMarkets.com’s offering. The research provides insights into Glaucoma epidemiology, Glaucoma diagnosed patients, and Glaucom…